Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology covers the translational toxicology of xenobiotics substances in carcinogenesis by explaining the toxicokinetic and toxicodynamic, toxicogenomic, biotransformation, and resistance mechanisms in the human body. The book begins with a historical review and link to future prospects for chemical carcinogenesis. It discusses major environmental xenobiotics and their risks in inducing cancer, along with content on toxic xenobiotics and their routes of exposure in humans, the role of xenobiotic metabolism in carcinogenesis,…mehr
Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology covers the translational toxicology of xenobiotics substances in carcinogenesis by explaining the toxicokinetic and toxicodynamic, toxicogenomic, biotransformation, and resistance mechanisms in the human body. The book begins with a historical review and link to future prospects for chemical carcinogenesis. It discusses major environmental xenobiotics and their risks in inducing cancer, along with content on toxic xenobiotics and their routes of exposure in humans, the role of xenobiotic metabolism in carcinogenesis, and the toxicokinetic and toxicodynamic of xenobiotics in cancer development. Lastly, the book explores current achievements such as using toxicogenomics for predicting the carcinogenicity of xenobiotic substances and the challenges posed by carcinogenic xenobiotic substances when examining preventive methods, diagnosis, and the development of anticancer drugs for specific toxicants.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Dr. Akhileshwar Kumar Srivastava works as a Research Associate (ICMR) in CSIR-Central Food Technological Research Institute, Mysore, India. In his eight years of research, he has published approximately 20 research articles and book chapters in international and national journals of repute. His research specialization is primarily in the area of pharmacognosy with genetics, metabolomics, bioinformatics, and molecular biology-associated targeting cancer diseases. In addition, he has studied at Augusta University (formerly, Georgia Regents University) in Augusta, GA, United States on a J-1 Exchange Scholar Visa and at Ben-Gurion University, Israel. He is also a life member fellow in Indian Science Congress and Agriculture, Nutrition and Health Academy, United Kingdom.
Inhaltsangabe
1. A historical review and future prospective of chemical carcinogenesis 2. Role of xenobiotics metabolism in carcinogenesis 3. Recalcitrant of toxic xenobiotics and its routes of exposure to human 4. Major environmental xenobiotics risk for different cancers 5. Toxicokinetic and toxicodynamic of xenobiotics in cancer development 6. Mechanism of oxidative stress in carcinogenesis induced by xenobiotics 7. Genotoxic and non-genotoxic activities of cancer-inducing xenobiotics 8. Modulation of epigenome by xenobiotics in cancer 9. Carcinogenic effects of nanomaterials with emphasis on nanoplastics 10. Endocrine disruptor activity of xenobiotics in carcinogenesis 11. Environmental exposures (Bisphenol A and phatalates) as xenoestrogens enhance risk for breast cancer 12. Biotransformation of toxic xenobiotics by human gut microbiota 13. Mechanism of resistance to toxic xenobiotics in human 14. Profiling the reactive metabolites of xenobiotics in cancer 15. Toxicogenomic for prediction of carcinogenicity of xenobiotic substances
1. A historical review and future prospective of chemical carcinogenesis 2. Role of xenobiotics metabolism in carcinogenesis 3. Recalcitrant of toxic xenobiotics and its routes of exposure to human 4. Major environmental xenobiotics risk for different cancers 5. Toxicokinetic and toxicodynamic of xenobiotics in cancer development 6. Mechanism of oxidative stress in carcinogenesis induced by xenobiotics 7. Genotoxic and non-genotoxic activities of cancer-inducing xenobiotics 8. Modulation of epigenome by xenobiotics in cancer 9. Carcinogenic effects of nanomaterials with emphasis on nanoplastics 10. Endocrine disruptor activity of xenobiotics in carcinogenesis 11. Environmental exposures (Bisphenol A and phatalates) as xenoestrogens enhance risk for breast cancer 12. Biotransformation of toxic xenobiotics by human gut microbiota 13. Mechanism of resistance to toxic xenobiotics in human 14. Profiling the reactive metabolites of xenobiotics in cancer 15. Toxicogenomic for prediction of carcinogenicity of xenobiotic substances
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826